Corticosteroid treatment for autoimmune pancreatitis

Published on Nov 1, 2009in Gut19.819
· DOI :10.1136/GUT.2009.183293
Rahul Pannala21
Estimated H-index: 21
(Mayo Clinic),
Suresh T. Chari83
Estimated H-index: 83
Autoimmune pancreatitis (AIP) is the only pancreatic disorder responsive to steroid treatment. AIP has recently been subclassified into type 1 and type 2 AIP.1 Type 1 AIP is the pancreatic manifestation of immunoglobulin G4 (IgG4)-associated systemic disease (ISD), a fibroinflammatory autoimmune disorder that involves multiple organ systems and is characteristically associated with elevation of serum levels of IgG4.2 Commonly used diagnostic criteria for AIP include the Asian Consensus diagnostic criteria3 and the Mayo Clinic HISORt criteria4 (histology, imaging, serology, other organ involvement and response to corticosteroid treatment). Treatment protocols for AIP are still evolving, but corticosteroids are generally considered to be very effective in the initial inflammatory phase of the disease. Several small case series have reported that corticosteroids are effective in inducing remission in AIP, but larger series and controlled trials are lacking. In this issue of Gut ( see page 1504 ), Kamisawa and colleagues5 report results from a large, multicentre, retrospective survey of 563 patients with AIP treated at 17 referral centres in Japan. Their study highlights the fact that though a substantial proportion of patients with AIP may achieve spontaneous remission (77/104 patients, 74%), corticosteroids are also highly effective in inducing remission (451/459 patients, 98%). This study, despite the limitations of a retrospective and cross-sectional study design, provides the best evidence to date of the efficacy of corticosteroid treatment in the initial presentation of AIP. However, our knowledge of the natural history of AIP, predictors of relapse, need for maintenance treatment and the optimal type of maintenance treatment is still limited. The objective of this commentary is to provide a brief overview of the issues associated with corticosteroid treatment in AIP. The goals of treatment in the initial inflammatory phase of AIP are symptom alleviation (eg, jaundice and abdominal discomfort), …
📖 Papers frequently viewed together
19 Authors (Terumi Kamisawa, ..., Masao Omata)
698 Citations
2,772 Citations
884 Citations
#1Phil A. Hart (The Ohio State University Wexner Medical Center)H-Index: 25
#2Yoh Zen (Kobe University)H-Index: 69
Last. Suresh T. Chari (Mayo Clinic)H-Index: 83
view all 3 authors...
Autoimmune pancreatitis (AIP) is distinct from calcifying and obstructive forms of chronic pancreatitis. Clinically and histologically it has two distinct subsets: (i) lymphoplasmacytic sclerosing pancreatitis or type 1 AIP which appears to be a systemic disease characterised by abundant infiltration of affected organs with immunoglobulin G4 (IgG4)-positive plasma cells and (2) duct-centric or type 2 AIP characterised by granulocyte epithelial lesions in the pancreas without systemic involvement...
411 CitationsSource
#1Terumi Kamisawa (Tokyo Metropolitan Komagome Hospital)H-Index: 60
#2Tooru Shimosegawa (Tohoku University)H-Index: 26
Last. Masao Omata (UTokyo: University of Tokyo)H-Index: 105
view all 19 authors...
Objective: To establish an appropriate steroid treatment regimen for autoimmune pancreatitis (AIP). Methods: A retrospective survey of AIP treatment was conducted in 17 centres in Japan. The main outcome measures were rate of remission and relapse. Results: Of 563 patients with AIP, 459 (82%) received steroid treatment. The remission rate of steroid-treated AIP was 98%, which was significantly higher than that of patients without steroid treatment (74%, 77/104; p Conclusions: The major indicatio...
698 CitationsSource
#1Makoto Otsuki (University of Occupational and Environmental Health Japan)H-Index: 33
#2Jae Bock ChungH-Index: 31
Last. Yasuyuki Kihara (University of Occupational and Environmental Health Japan)H-Index: 18
view all 15 authors...
In 2002, the Japan Pancreas Society (JPS) was the first in the world to propose diagnostic criteria for autoimmune pancreatitis (AIP). Since the concept of AIP has changed with the accumulation of AIP cases, the Research Committee of Intractable Pancreatic Diseases (RCIPD) provided by the Ministry of Health, Labour and Welfare of Japan and the JPS issued revised clinical diagnostic criteria of AIP in 2006. The Asan Medical Center of Korea also proposed diagnostic criteria for AIP in 2006. Howeve...
564 CitationsSource
#1Amaar Ghazale (Mayo Clinic)H-Index: 8
#2Suresh T. Chari (Mayo Clinic)H-Index: 83
Last. Michael B. Farnell (Mayo Clinic)H-Index: 71
view all 13 authors...
Background & Aims: Immunoglobulin (Ig)G4-associated cholangitis (IAC) is the biliary manifestation of a steroid-responsive multisystem fibroinflammatory disorder in which affected organs have a characteristic lymphoplasmacytic infiltrate rich in IgG4-positive cells. We describe clinical features, treatment response, and predictors of relapse in IAC and compare relapse rates in IAC with intrapancreatic vs proximal bile duct strictures. Methods: We reviewed clinical, serologic, and imaging charact...
884 CitationsSource
#1Terumi KamisawaH-Index: 60
#2Atsutake OkamotoH-Index: 28
Last. Norio Sawabu (Kanazawa University)H-Index: 29
view all 5 authors...
Objective. Because autoimmune pancreatitis (AIP) responds well to corticosteroids, many AIP patients are given this treatment. However, there is no consensus on the indications, dose, or duration of steroid treatment. The aim of this study was to establish the most appropriate steroid therapy regimen. Material and methods. We retrospectively reviewed morphological and serological improvement after steroid therapy and long-term outcome including relapse in 41 AIP patients who were given steroid t...
103 CitationsSource
#1Amaar Ghazale (Mayo Clinic)H-Index: 8
#2Suresh T. ChariH-Index: 83
Unanswered questions Autoimmune pancreatitis (AIP) is part of a systemic fibro-inflammatory disease that can involve multiple organs which characteristically have a lymphoplasmacytic infiltrate rich in IgG4-positive cells. IgG4-related systemic disease (ISD) has been proposed by Kamisawa et al as the umbrella term to describe this multi-organ disease.1 Although the fibrosis in ISD can often lead to damage and even destruction of the involved organ, the inflammatory process typically responds to ...
116 CitationsSource
#1Nicholas I. Church (UCLH: University College Hospital)H-Index: 12
#2Stephen P. PereiraH-Index: 47
Last. George WebsterH-Index: 33
view all 12 authors...
Autoimmune Pancreatitis: Clinical and Radiological Features and Objective Response to Steroid Therapy in a UK Series
207 CitationsSource
#1Kenji Hirano (UTokyo: University of Tokyo)H-Index: 39
#2Minoru TadaH-Index: 46
Last. Masao OmataH-Index: 105
view all 12 authors...
Objectives: Autoimmune pancreatitis (AIP) is a unique form of chronic pancreatitis, and it has a favorable response to corticosteroid treatment (CST). However, little is known about the long-term outcome of AIP. We aimed to document the prognosis without and with CST, and to examine the indication for CST. Patients and Methods: Prognosis and clinical features of 23 patients without CST and 19 patients treated with CST from onset were investigated. In addition, we examined factors concerning the ...
309 CitationsSource
#1Suresh T. Chari (Mayo Clinic)H-Index: 83
#2Thomas C. Smyrk (Mayo Clinic)H-Index: 98
Last. Michael B. Farnell (Mayo Clinic)H-Index: 71
view all 11 authors...
Background & Aims: The Japan Pancreas Society criteria for diagnosis of autoimmune pancreatitis (AIP) mandate presence of characteristic imaging (diffuse pancreatic enlargement with diffusely irregular, narrow pancreatic duct). AIP has unique histologic features associated with infiltration of tissues of affected organs with abundant IgG4-positive cells. We propose expanded diagnostic criteria for AIP with a cohort of histologically confirmed AIP. Methods: We reviewed the pancreatic imaging find...
1,118 CitationsSource
259 CitationsSource
Cited By69
#1Wen Zhang (Peking Union Medical College Hospital)H-Index: 26
#2John H. Stone (Harvard University)H-Index: 76
Summary IgG4-related disease was unrecognised as a unified disease entity until this century, yet in a short period of time the disease has been appreciated to have a worldwide distribution, and its clinical, pathological, and radiological features have been described in considerable detail. The disease has strong organ predilections, and many of the clinical presentations of disease are increasingly familiar to both generalists and specialists. Early recognition of IgG4-related disease is cruci...
10 CitationsSource
#1Matteo Tacelli (University of Palermo)H-Index: 5
#2Ciro Celsa (University of Palermo)H-Index: 7
Last. Calogero Cammà (University of Palermo)H-Index: 61
view all 9 authors...
Background & Aims Risk for relapse after induction of remission with steroid therapy has been studied extensively in patients with autoimmune pancreatitis (AIP), but findings have been equivocal. We performed a systematic review and meta-analysis to estimate the relapse rate of AIP after initial remission after steroid treatment and to identify factors associated with relapse. Methods Three reviewers searched MEDLINE, SCOPUS, and EMBASE until July 2018 to identify studies on rate of relapse of A...
9 CitationsSource
#1Henry Y. Jiang (Northern Ontario School of Medicine)H-Index: 3
#2Erica L. Kohtakangas (Northern Ontario School of Medicine)H-Index: 3
Last. Jeffrey B. Shum (Northern Ontario School of Medicine)H-Index: 1
view all 5 authors...
1 CitationsSource
#1Luca FrulloniH-Index: 44
#2Nicolò de PretisH-Index: 6
Last. Antonio AmodioH-Index: 13
view all 3 authors...
Autoimmune pancreatitis (AIP) is a fibro-inflammatory disease of the pancreas with a postulated immune-mediated mechanism (1,2). Two different histologic subtypes have been described, type 1 and type 2 AIP (3). Type 1 AIP is a more aggressive disease in terms of recurrences and extra-pancreatic organ involvement. International consensus diagnostic criteria (ICDC) have been established to classify the disease without definitive histology (4). ICDC introduced not otherwise specified (NOS) AIP as a...
5 CitationsSource
#1Atsushi Masamune (Tohoku University)H-Index: 53
#2Isao NishimoriH-Index: 42
Last. Tooru Shimosegawa (Tohoku University)H-Index: 69
view all 29 authors...
Objective Corticosteroid has been established as the standard therapy for autoimmune pancreatitis (AIP), but the requirement for maintenance corticosteroid therapy is controversial. We conducted a randomised controlled trial to clarify the efficacy of maintenance corticosteroid therapy in patients with AIP. Design We conducted a multicentre, tertiary setting, randomised controlled trial. After the induction of remission with the initial oral prednisolone (PSL) treatment, maintenance therapy with...
77 CitationsSource
#1Atsushi Masamune (Tohoku University)H-Index: 53
#2Atsushi Kanno (Tohoku University)H-Index: 16
Last. Aliye Uc (Roy J. and Lucille A. Carver College of Medicine)H-Index: 25
view all 9 authors...
Autoimmune pancreatitis (AIP) is a rare pancreatic disorder that can present as a manifestation of a broader systemic inflammatory disease known as immunoglobulin G4-related systemic disease (IGG4-RSD). AIP is divided into two subtypes based on clinical, radiological, and histological findings. The disease can be mistaken for pancreatic cancer because of overlapping clinical and radiological findings, but early recognition can help avoid unnecessary surgery. We present a case of a 65-year-old fe...
#1C. Rousselin (university of lille)H-Index: 1
#2F. Pontana (university of lille)H-Index: 1
Last. Marc Lambert (university of lille)H-Index: 42
view all 4 authors...
Resume Les aortites sont principalement retrouvees au cours des maladies inflammatoires comme l’arterite de Takayasu, l’arterite a cellules geantes ou la maladie de Behcet. Dans certains cas, l’aortite est dite idiopathique lorsqu’aucune de ces causes n’est retrouvee. Certains diagnostics differentiels doivent cependant etre evoques car leur prise en charge est bien differente. En premier lieu, il faut eliminer une cause infectieuse de l’aortite car leur rapidite d’evolution et leur pronostic a ...
6 CitationsSource
Abstract IgG4-related disease (IgG4-RD) is a recently recognized chronic fibrotic inflammation, which can affect almost every organ, and may come to clinical attention first due to visible organ swelling or organ dysfunction, or is identified incidentally by imaging and specific biopsy. The disorder has an allergic background and is immune-mediated. Up-regulated responses of T helper 2 and T regulatory cells and their cytokines play a major role in disease progression. About 30–50% of patients a...
60 CitationsSource